J&J's DePuy to end 2 hip replacement systems
Johnson & Johnson's DePuy orthopedics business plans to stop selling a couple of hip replacement systems not widely used by doctors. Full story
Johnson & Johnson's DePuy orthopedics business plans to stop selling a couple of hip replacement systems not widely used by doctors. Full story
TODAY’s Sara Haines introduces the latest adorable additions to Johnson & Johnson’s “Baby of the Week” segment.
Several Johnson & Johnson shareholders took the health care giant to task during its annual meeting Thursday, criticizing management for repeated product recalls, ethical lapses and excessive executive pay. Full story
Alex Gorksy, Johnson & Johnson chairman & CEO, offers insight on the firm's quarter and forecast for the year ahead.
Shares of Target are lower after the retailer warned its Q1 earnings would miss expectations, and Johnson & Johnson is up after reporting strong earnings, with the FMHR traders.
The "Squawk on the Street" news crew takes a closer look at three companies reporting first quarter numbers; including Johnson & Johnson, W.W. Grainger, and Goldman Sachs.
Johnson & Johnson just won approval for a new diabetes drug, and the stock is at an all-time high today. Anthony Butler, Barclays, offers insight.
David Darst, Morgan Stanley Wealth Management, explains why he is positive on Johnson & Johnson, Schlumberger, and Microsoft.
Every week, with the help of Johnson & Johnson, TODAY’s Fourth Hour brings you the cutest, most adorable baby photos submitted to us by loving parents.
A jury has awarded more than $8 million to a man who accused a subsidiary of Johnson & Johnson of knowingly marketing a defective hip replacement that was later recalled. NBC’s Brian Williams reports.
Has the economy turned the corner?; Sequestration a symptom of Washington dysfunction; Conclave to begin Tuesday; Oceanfront home rips off its foundation; Chavez funeral brings dignitaries from around the world; European weather forecasts superior to US models; Ashley Judd may run for U.S. Senate; J
A first aid kit made by Johnson & Johnson for sale on a store shelf in Westminster, Colorado April 14, 2009. REUTERS/Rick Wilking
Products made by Johnson & Johnson for sale on a store shelf in Westminster, Colorado in this April 14, 2009, file photo. Johnson & Johnson beat Wall Street's quarterly profit estimates on sharply lower taxes, strong sales of prescription drugs and a revival of over-the-counter medicines that had be
A first aid kit made by Johnson & Johnson for sale on a store shelf in Westminster, Colorado in this April 14, 2009, file photo. Johnson & Johnson beat Wall Street's quarterly profit estimates on sharply lower taxes, strong sales of prescription drugs and a revival of over-the-counter medicines that